Trials / Completed
CompletedNCT01058694
The Impact of Short Message Services (SMS) on ARV Adherence in Western Kenya
Adherence to ARV Treatment and Its Effects on Medium Run Socio-Economic Outcomes: Evidence From Western Kenya
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 720 (actual)
- Sponsor
- Georgetown University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of proposed research is to implement a randomized study that will allow us to understand and address a number of key barriers to patient adherence as well as study the effects of better adherence on health and socio-economic outcomes.
Detailed description
Several studies have shown that proper adherence to treatment regimens is essential for the effectiveness of ARV therapy (e.g Wools-Kaloustian et al. 2006). There is also evidence in that in some treatment programs in Africa, adherence rates are not always high (Gill et al. 2005). Even in settings where adherence levels are found to be high, numerous factors have been identified as being relevant, although the causal effects are unknown (Castro, 2006). As ARV treatment programs are scaled up in Africa, it is essential to understand the socio-economic determinants of adherence to ARV treatment, as well as the impact of interventions to support high levels of adherence. A secondary objective of this study is to understand the socio-economic impacts of higher adherence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Short Message Services to Support ARV therapy adherence | Short message services were sent to randomly selected consenting subjects on ARV therapy. The frequency and content of the message is varied in a factorial design. |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2008-12-01
- Completion
- 2009-07-01
- First posted
- 2010-01-29
- Last updated
- 2010-01-29
Locations
1 site across 1 country: Kenya
Source: ClinicalTrials.gov record NCT01058694. Inclusion in this directory is not an endorsement.